GELESIS Superabsorbent Hydrogel Prevents Hepatic Steatosis and Insulin Resistance in High Fat Diet–Induced NAFLD Pre-Clinical Model
GS300 Novel, Non-Systemic, Superabsorbent Hydrogel Improves Intestinal Barrier Function in Intestinal Injury Pre-Clinical Model
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Effect of a nonsystemic, orally administered hydrogel, GS100, on metformin pharmacokinetics
Satiety, Weight Loss, and Glycemic Control-Enhancing Properties Vary Between Functional Fibers, Mixed Vegetables, and a Novel Hydrogel (Gelesis200)
Effects of Gelesis200 on fullness and satiety presented at TOS Obesity Week.